Safety, tolerability, and efficacy of intracranial delivery of autologous iPSC-derived dopaminergic precursors in moderate to advanced Parkinson’s Disease
2025 · Parkinsonism & Related Disorders · 1 citations
https://doi.org/10.1016/j.parkreldis.2025.107630